Stay updated on IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial

Sign up to get notified when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No significant changes detected in the Study Details page; the content remains the same.
    Difference
    0.4%
    Check dated 2025-11-03T20:48:29.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.
    Difference
    3%
    Check dated 2025-10-06T05:11:37.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Updated revision to v3.1.0 with new contact details (medaly@ucdavis.edu, 916-734-5428) and removed prior topic (head and neck squamous cell carcinoma); core page content appears to be updated mainly through versioning and contact information, with a notable removal of a medical topic.
    Difference
    0.2%
    Check dated 2025-09-29T02:59:27.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, signaling a new release. The 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:56:30.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T13:54:58.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility and location information, as well as additional medical topics related to various cancers and therapies, while removing some previously listed locations and topics.
    Difference
    4%
    Check dated 2025-08-31T11:37:26.000Z thumbnail image

Stay in the know with updates to IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.